Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria S Tretiakova

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Journal of Carcinogenesis|December 4, 2009
MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancerLeonardo Faoro, Gustavo M Cervantes, Benjamin D Ferguson, et al.
Cancer Research|March 1, 2005
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancerPatrick C Ma, Ramasamy Jagadeeswaran, Simha Jagadeesh, et al.
Molecular Systems Biology|April 17, 2008
Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progressionSujun Hua, Caleb B Kallen, Ruby Dhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinomaMin-Han Tan, Carl Morrison, Pengfei Wang, et al.
The Journal of Infectious Diseases|March 16, 2011
Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki diseaseAnne H Rowley, Susan C Baker, Stanford T Shulman, et al.
Bladder Cancer (Amsterdam, Netherlands)|June 10, 2021
Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomesLeonidas N Diamantopoulos, Ali Raza Khaki, Petros Grivas, et al.
Plos One|July 12, 2013
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic targetBenjamin D Ferguson, Ren Liu, Cleo E Rolle, et al.
Cancer Research Communications|November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterationsRadhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
The American Journal of Surgical Pathology|August 6, 2014
Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patientsJuan Guo, Maria S Tretiakova, Megan L Troxell, et al.
JCO Precision Oncology|May 25, 2019
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene MutationsMichael T Schweizer, Emmanuel S Antonarakis, Tarek A Bismar, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Journal of Carcinogenesis|December 4, 2009
MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancerLeonardo Faoro, Gustavo M Cervantes, Benjamin D Ferguson, et al.
Cancer Research|March 1, 2005
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancerPatrick C Ma, Ramasamy Jagadeeswaran, Simha Jagadeesh, et al.
Molecular Systems Biology|April 17, 2008
Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progressionSujun Hua, Caleb B Kallen, Ruby Dhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinomaMin-Han Tan, Carl Morrison, Pengfei Wang, et al.
The Journal of Infectious Diseases|March 16, 2011
Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki diseaseAnne H Rowley, Susan C Baker, Stanford T Shulman, et al.
Bladder Cancer (Amsterdam, Netherlands)|June 10, 2021
Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomesLeonidas N Diamantopoulos, Ali Raza Khaki, Petros Grivas, et al.
Plos One|July 12, 2013
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic targetBenjamin D Ferguson, Ren Liu, Cleo E Rolle, et al.
Cancer Research Communications|November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterationsRadhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
The American Journal of Surgical Pathology|August 6, 2014
Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patientsJuan Guo, Maria S Tretiakova, Megan L Troxell, et al.
JCO Precision Oncology|May 25, 2019
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene MutationsMichael T Schweizer, Emmanuel S Antonarakis, Tarek A Bismar, et al.
Pageof 9